28.09
price down icon4.91%   -1.45
pre-market  プレマーケット:  28.76   0.67   +2.39%
loading
前日終値:
$29.54
開ける:
$29.54
24時間の取引高:
465.20K
Relative Volume:
1.35
時価総額:
$519.10M
収益:
$294.28M
当期純損益:
$367.02M
株価収益率:
1.4853
EPS:
18.9115
ネットキャッシュフロー:
$75.66M
1週間 パフォーマンス:
-8.08%
1か月 パフォーマンス:
+2.03%
6か月 パフォーマンス:
-25.79%
1年 パフォーマンス:
+46.99%
1日の値動き範囲:
Value
$27.70
$30.06
1週間の範囲:
Value
$27.70
$30.41
52週間の値動き範囲:
Value
$16.88
$52.24

Rigel Pharmaceuticals Stock (RIGL) Company Profile

Name
名前
Rigel Pharmaceuticals
Name
セクター
Healthcare (1106)
Name
電話
650-624-1100
Name
住所
611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, CA
Name
職員
174
Name
Twitter
@rigelpharma
Name
次回の収益日
2026-05-05
Name
最新のSEC提出書
Name
RIGL's Discussions on Twitter

Compare RIGL vs VRTX, REGN, ARGX, ALNY, ONC

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
RIGL icon
RIGL
Rigel Pharmaceuticals
28.09 519.10M 294.28M 367.02M 75.66M 18.91
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
424.36 107.87B 12.32B 4.34B 3.19B 16.86
REGN icon
REGN
Regeneron Pharmaceuticals Inc
702.27 73.63B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
794.70 49.42B 4.16B 1.29B 734.26M 19.58
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
301.11 40.20B 3.71B 313.75M 465.38M 2.2571
ONC icon
ONC
Beone Medicines Ltd Adr
297.49 33.06B 5.36B 287.73M 924.18M 2.5229

Rigel Pharmaceuticals Stock (RIGL) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-11-05 アップグレード Jefferies Hold → Buy
2023-04-03 再開されました Piper Sandler Neutral
2022-06-09 ダウングレード Citigroup Buy → Neutral
2022-06-08 ダウングレード Cantor Fitzgerald Overweight → Neutral
2022-06-08 ダウングレード Piper Sandler Overweight → Neutral
2022-03-23 開始されました B. Riley Securities Neutral
2020-11-09 ダウングレード JP Morgan Overweight → Neutral
2019-11-15 再開されました Cantor Fitzgerald Overweight
2019-09-26 再開されました JP Morgan Overweight
2019-03-01 繰り返されました Cantor Fitzgerald Overweight
2018-08-27 開始されました Citigroup Buy
2018-05-02 繰り返されました Cantor Fitzgerald Overweight
2017-12-21 再開されました Piper Jaffray Overweight
2017-12-15 開始されました Cantor Fitzgerald Overweight
2017-11-06 再開されました H.C. Wainwright Buy
2017-03-09 繰り返されました H.C. Wainwright Buy
2016-08-31 繰り返されました H.C. Wainwright Buy
2016-08-30 繰り返されました Piper Jaffray Overweight
2016-07-13 開始されました H.C. Wainwright Buy
2016-06-13 開始されました Piper Jaffray Overweight
2016-04-22 アップグレード JP Morgan Neutral → Overweight
2013-04-08 繰り返されました Stifel Buy
2012-11-29 開始されました UBS Neutral
2012-11-06 繰り返されました Oppenheimer Outperform
2012-03-26 開始されました Canaccord Genuity Hold
2010-12-10 ダウングレード MP Advisors Outperform → Market Perform
すべてを表示

Rigel Pharmaceuticals (RIGL) 最新ニュース

pulisher
May 05, 2026

Rigel Pharmaceuticals Q1 Earnings Call Highlights - Yahoo Finance

May 05, 2026
pulisher
May 05, 2026

Rigel Pharmaceuticals reports Q1 EPS 44c, consensus 87c - TipRanks

May 05, 2026
pulisher
May 05, 2026

Rigel Pharmaceuticals : Quarterly Report for Quarter Ending MARCH 31, 2026 (Form 10-Q) - marketscreener.com

May 05, 2026
pulisher
May 05, 2026

Rigel Pharmaceuticals (RIGL) Lags Q1 Earnings and Revenue Estimates - Yahoo Finance

May 05, 2026
pulisher
May 05, 2026

Earnings call transcript: Rigel Pharmaceuticals Q1 2026 sees revenue growth, stock dips - Investing.com

May 05, 2026
pulisher
May 05, 2026

Rigel Pharmaceuticals Q1 2026 Earnings Call: Complete Transcript - Benzinga

May 05, 2026
pulisher
May 05, 2026

Rigel Pharmaceuticals (NASDAQ:RIGL) Q1 2026 Results Miss Revenue and EPS Estimates, Stock Declines After-Hours - ChartMill

May 05, 2026
pulisher
May 05, 2026

Rigel: Q1 Earnings Snapshot - marketscreener.com

May 05, 2026
pulisher
May 05, 2026

Rigel (NASDAQ: RIGL) grows Q1 2026 sales, ends Lilly RIPK1 deal - Stock Titan

May 05, 2026
pulisher
May 05, 2026

Rigel (NASDAQ: RIGL) grows Q1 2026 drug sales, reaffirms 2026 outlook - Stock Titan

May 05, 2026
pulisher
May 05, 2026

Rigel Reports First Quarter 2026 Financial Results - PR Newswire

May 05, 2026
pulisher
May 05, 2026

MSN Money - MSN

May 05, 2026
pulisher
May 03, 2026

Hussman Strategic Advisors Inc. Buys New Shares in Rigel Pharmaceuticals, Inc. $RIGL - MarketBeat

May 03, 2026
pulisher
May 02, 2026

Universal Beteiligungs und Servicegesellschaft mbH Buys Shares of 55,200 Rigel Pharmaceuticals, Inc. $RIGL - MarketBeat

May 02, 2026
pulisher
May 01, 2026

RIGL Stock Price, Quote & Chart | RIGEL PHARMACEUTICALS INC (NASDAQ:RIGL) - ChartMill

May 01, 2026
pulisher
Apr 30, 2026

Q1 2026 results and business update set for May 5, Rigel Pharmaceuticals confirms - Traders Union

Apr 30, 2026
pulisher
Apr 29, 2026

Earnings Preview: RIGL to Report Financial Results Post-market on May 05 - 富途牛牛

Apr 29, 2026
pulisher
Apr 29, 2026

Rigel Pharmaceuticals (RIGL) to report Q1 results: Wall Street expects earnings growth - MSN

Apr 29, 2026
pulisher
Apr 29, 2026

Rigel Announces Conference Call and Webcast to Report First Quar - GuruFocus

Apr 29, 2026
pulisher
Apr 28, 2026

Is the options market predicting a spike in Rigel Pharmaceuticals stock? - MSN

Apr 28, 2026
pulisher
Apr 28, 2026

Rigel Pharmaceuticals (RIGL) to Release Earnings on Tuesday - MarketBeat

Apr 28, 2026
pulisher
Apr 28, 2026

Rigel Pharmaceuticals (RIGL) to Report Q1 Results: Wall Street Expects Earnings Growth - Yahoo Finance

Apr 28, 2026
pulisher
Apr 28, 2026

Rigel Announces Conference Call and Webcast to Report First Quarter 2026 Financial Results - Moomoo

Apr 28, 2026
pulisher
Apr 27, 2026

RIGEL PHARMACEUTICALS INC (RIGL) Fundamental Analysis & Valuation - ChartMill

Apr 27, 2026
pulisher
Apr 25, 2026

Piper Sandler Maintains Rigel Pharmaceuticals(RIGL.US) With Hold Rating, Cuts Target Price to $40 - 富途牛牛

Apr 25, 2026
pulisher
Apr 25, 2026

Behavioral Patterns of RIGL and Institutional Flows - Stock Traders Daily

Apr 25, 2026
pulisher
Apr 24, 2026

Is the Options Market Predicting a Spike in Rigel Pharmaceuticals Stock? - Yahoo Finance

Apr 24, 2026
pulisher
Apr 24, 2026

Eli Lilly terminates agreement with Rigel Pharmaceuticals - medwatch.com

Apr 24, 2026
pulisher
Apr 23, 2026

Eli Lilly terminates license agreement with Rigel over ocadusertib - MSN

Apr 23, 2026
pulisher
Apr 23, 2026

Ruffer LLP Invests $1.60 Million in Rigel Pharmaceuticals, Inc. $RIGL - MarketBeat

Apr 23, 2026
pulisher
Apr 23, 2026

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Apr 23, 2026
pulisher
Apr 22, 2026

RIGL (Rigel Pharmaceuticals Inc.) climbs two percent after Q4 2025 results, even as EPS falls short of analyst forecasts.Verified Stock Signals - Xã Châu Thành

Apr 22, 2026
pulisher
Apr 22, 2026

Biopharma bites: Sarclisa's delayed review, Lilly exits Rigel pact, Amneal's biosimilar buy and more from Sanofi, Ipsen - FirstWord Pharma

Apr 22, 2026
pulisher
Apr 22, 2026

Lilly reneges on remainder of Rigel deal in another blow for RIPK1 inhibitors - Fierce Biotech

Apr 22, 2026
pulisher
Apr 22, 2026

Rigel Pharmaceuticals (NASDAQ:RIGL) Shares Down 5.1%Time to Sell? - MarketBeat

Apr 22, 2026
pulisher
Apr 22, 2026

Lilly exits Rigel alliance, adding to RIPK1 scrap heap - BioSpace

Apr 22, 2026
pulisher
Apr 22, 2026

H.C. Wainwright Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Maintains Target Price $57 - Moomoo

Apr 22, 2026
pulisher
Apr 21, 2026

Eli Lilly Ends Collaboration with Rigel Pharmaceuticals (LLY) - GuruFocus

Apr 21, 2026
pulisher
Apr 21, 2026

Rigel Pharmaceuticals Inc on April 16, received written notice from Eli Lilly - marketscreener.com

Apr 21, 2026
pulisher
Apr 21, 2026

Rigel Pharmaceuticals Inc On April 16, Received Written Notice From Eli Lilly - TradingView

Apr 21, 2026
pulisher
Apr 21, 2026

Rigel Pharmaceuticals to regain rights to ocadusertib after Eli Lilly ends agreement - Investing.com Nigeria

Apr 21, 2026
pulisher
Apr 21, 2026

Rigel Regains Rights as Eli Lilly Ends Collaboration - TipRanks

Apr 21, 2026
pulisher
Apr 21, 2026

Rigel Pharmaceuticals to Regain Rights as Lilly Terminates RIPK1 License and Collaboration - TradingView

Apr 21, 2026
pulisher
Apr 21, 2026

Eli Lilly ends Rigel (RIGL) RIPK1 licensing deal, no future milestones - Stock Titan

Apr 21, 2026
pulisher
Apr 16, 2026

Rigel Pharmaceuticals (RIGL) Stock: Reversal Signals (-0.90%) 2026-04-16High Attention Stocks - Cổng thông tin điện tử tỉnh Lào Cai

Apr 16, 2026
pulisher
Apr 16, 2026

Rigel Pharmaceuticals, Inc. (RIGL) Stock Analysis: A Biotech Player with 59.70% Upside Potential - DirectorsTalk Interviews

Apr 16, 2026
pulisher
Apr 14, 2026

(RIGL) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily

Apr 14, 2026
pulisher
Apr 12, 2026

Why Rigel Pharmaceuticals Lost Big in December - AOL.com

Apr 12, 2026
pulisher
Apr 12, 2026

Ritholtz Wealth Management Boosts Rigel Pharmaceuticals Holdings - National Today

Apr 12, 2026
pulisher
Apr 12, 2026

Ritholtz Wealth Management Acquires 72,999 Shares of Rigel Pharmaceuticals, Inc. $RIGL - MarketBeat

Apr 12, 2026
pulisher
Apr 10, 2026

Why VAALCO Energy, Rigel Pharmaceuticals, and Companhia Siderurgica Nacional Are Today's 3 Best Stoc - Yahoo

Apr 10, 2026

Rigel Pharmaceuticals (RIGL) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$28.32
price down icon 0.14%
$50.44
price up icon 0.48%
$95.50
price down icon 3.88%
$139.44
price down icon 0.41%
$147.21
price down icon 0.47%
ONC ONC
$297.49
price up icon 0.12%
大文字化:     |  ボリューム (24 時間):